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Abstract
Background: We have previously shown that efficiency of ischemic conditioning is diminished in hypercholesterolemia
and that autophagy is necessary for cardioprotection. However, it is unknown whether isolated hypercholesterolemia
disturbs autophagy or the mammalian target of rapamycin (mTOR) pathways. Therefore, we investigated whether
isolated hypercholesterolemia modulates cardiac autophagy-related pathways or programmed cell death mechanisms
such as apoptosis and necroptosis in rat heart.
Methods: Male Wistar rats were fed either normal chow (NORM; n = 9) or with 2% cholesterol and 0.25% cholic acid-
enriched diet (CHOL; n = 9) for 12 weeks. CHOL rats exhibited a 41% increase in plasma total cholesterol level over
that of NORM rats (4.09 mmol/L vs. 2.89 mmol/L) at the end of diet period. Animals were sacrificed, hearts were excised
and briefly washed out. Left ventricles were snap-frozen for determination of markers of autophagy, mTOR pathway,
apoptosis, and necroptosis by Western blot.
Results: Isolated hypercholesterolemia was associated with a significant reduction in expression of cardiac autophagy
markers such as LC3-II, Beclin-1, Rubicon and RAB7 as compared to controls. Phosphorylation of ribosomal
S6, a surrogate marker for mTOR activity, was increased in CHOL samples. Cleaved caspase-3, a marker of
apoptosis, increased in CHOL hearts, while no difference in the expression of necroptotic marker RIP1, RIP3
and MLKL was detected between treatments.
Conclusions: This is the first comprehensive analysis of autophagy and programmed cell death pathways of apoptosis
and necroptosis in hearts of hypercholesterolemic rats. Our data show that isolated hypercholesterolemia suppresses
basal cardiac autophagy and that the decrease in autophagy may be a result of an activated mTOR pathway. Reduced
autophagy was accompanied by increased apoptosis, while cardiac necroptosis was not modulated by
isolated hypercholesterolemia. Decreased basal autophagy and elevated apoptosis may be responsible for
the loss of cardioprotection reported in hypercholesterolemic animals.
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Background
Hyperlipidemias have significant cardiac consequences,
since they are among the major risk factors of ischemic
heart diseases [1]. The role of atherosclerosis is well
studied in these pathologies; however, myocardial effects
of hyperlipidemias that do not result in atherosclerosis,
such as isolated hypercholesterolemia, is less well
understood. Hypercholesterolemia was previously shown
to worsen cardiac systolic and diastolic function in
cholesterol-fed rabbits [2]. Furthermore, we have previ-
ously shown that cholesterol feeding leads to mild con-
tractile dysfunction and cardiac oxidative stress [3].
These data suggest that cardiac metabolism may be
affected by hypercholesterolemia well before or even
without the development of atherosclerosis. However, it
is not well studied which molecular pathways are
responsible for the cardiac metabolic effects of
hypercholesterolemia.
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Autophagy is a ubiquitous cellular housekeeping
process [4–6], which is involved in protein quality con-
trol and cardiac cytoprotection [7–9]. It is known that
autophagy is elevated under nutrient and oxidative stress
in ischemia-reperfusion injury [10]. We have previously
shown that ischemic preconditioning induces autophagy
under normal conditions in adult rat hearts and that au-
tophagy is necessary for cardioprotection by ischemic
preconditioning [11]. Similarly, Rohailla et al. showed
that remote ischemic preconditioning increases autoph-
agy and decreased the expression of proteins related to
the major regulator of autophagy the mammalian target
of rapamycin (mTOR) in mice [12]. It is well established
that activity of mTOR pathway modulates autophagy
[13]. Previous data suggests that mTOR signaling might
be elevated while autophagy is diminished in the hearts
of hyperlipidemic Yucatan pigs [14], and we have shown
that in mice diet-induced obesity results in disturbed
cardiac autophagy which is accompanied by increased
myocardial injury after ischemia/reperfusion [15]. Cardi-
oprotective effects of ischemic conditioning are attenu-
ated in the presence of cardiovascular risk factors such
as aging [16, 17], diabetes [18, 19] and hyperlipidemia
[20, 21]. Similarly, our previous studies demonstrated
that cardioprotection by various forms of ischemic con-
ditioning is impaired in cholesterol-fed rats [22–25].
However, there is no information whether isolated
hypercholesterolemia modulates cardiac autophagy and
mTOR pathways in rats.
Insufficient autophagy can promote programmed cell
death, apoptosis [26], which results in cardiac damage
[27]. Necroptosis (programmed necrosis) is another type
of programmed cell death which occurs upon stimula-
tion of death receptors in the absence of caspase-8 acti-
vation [28]. Disturbances in cellular energetics, excessive
reactive oxygen species production or metabolic changes
have been shown to elicit necroptosis and apoptosis
[29–32]. It has been shown that apoptosis is upregulated
in the hearts of hamsters on hypercholesterolemic diet
[30]. Furthermore, Ye et al. showed that TNFα-induced
oxidative stress increased necroptosis in parallel with
autophagy [33]. Thus, we speculated that isolated hyper-
cholesterolemia may also increase activation of pro-
death pathways such as apoptosis and necroptosis in the
rat heart.
Therefore, our hypothesis was that (1) cardiac autoph-
agy is diminished in isolated hypercholesterolemia due
to increased mTOR signaling, and that (2) pro-death
pathways such as apoptosis or necroptosis are upregu-
lated in hypercholesterolemia. Accordingly, the aims of
the present study were to investigate the status of
autophagy and mTOR pathways in isolated hypercholes-
terolemia and to examine apoptosis and necroptosis in a
hypercholesterolemic rat model.
Methods
Animal model
Six-weeks-old male Wistar rats (Crl:WI Strain Code:
003; Charles River Laboratories, Wilmington, MA, USA)
were fed with control chow (NORM; n = 9) or chow
enriched with 2% cholesterol and 0.25% cholic acid
(CHOL; n = 9) for 12 weeks (Table 1). Animals were
allowed to food and water ad libitum and chow was
changed daily. After the feeding period, body weight of
animals were measured and they were anesthetized with
diethyl ether and given 500 U/kg heparin i.v. Blood
sample (500 μL) was taken from tail vein for further
experiments. Hearts were excised and perfused with
Krebs-Henseleit buffer according to Langendorff at 37 °C
for 10 min as previously described [34]. Hearts were taken
and snap-frozen for further biochemical assays.
Measurements of glucose and serum lipids
After the 12 week-weeks-long feeding period, glucose,
cholesterol and triglyceride levels were measured from
plasma of NORM and CHOL rats by colorimetric as-
says (Diagnosticum, Budapest, Hungary) as previously
described [35].
Table 1 Chow composition and nutritional data of chows
NORM CHOL
Cholesterol 0.0 2.0
Cholic acid 0.0 0.25
Corn 20.0 20.0
Extracted soybean meal 17.0 17.0
Extracted sunflower seed meal 8.0 8.0
Gluten/corn 4.0 4.0
Protein powder, PL68 1.7 1.7
Wheat middlings 41.7 39.4
Feed lime 1.2 1.2
Calcium phosphate 0.4 0.4
Sodium chloride 0.4 0.4
Zeolite, universal 4.5 4.5
Adhesive 0.6 0.6
Vitamin and trace element supplement 0.5 0.5
Nutritional composition
Raw protein 22.0 22.0
Raw fat 3.3 3.3
Starch 21.4 20.7
Sugar 5.0 4.9
Raw fiber 6.3 6.3
Raw ash 9.3 9.3
Solids 88.4 88.4
Gross energy (Mj/kg) 14.9 14.5
Data are expressed in % or otherwise noted
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Measurement of markers of autophagy, mTOR apoptosis
and necroptosis by Western blot
Freeze-clamped left ventricles were ground in liquid
nitrogen and homogenized with TissueLyser LT
(Qiagen, Venlo, The Netherlands) in ice-cold RIPA
homogenization buffer (Millipore, Darmstadt, Germany),
containing phenylmethylsulfonyl fluoride protease in-
hibitor (Roche, Basel, Switzerland) and phosphatase
inhibitor cocktail (1 mM sodium orthovanadate,
100 mM sodium fluoride and 17.5 mM β-glycero-
phosphate; Sigma, St. Louis, MO, USA). Protein con-
centration was assessed with BCA kit (Thermo Fisher
Scientific, Waltham, MA, USA). Protein samples were
resolved on 4–20% Criterion TGX gels (Bio-Rad,
Hercules, CA, USA) and transferred to Immun-Blot
PVDF membranes (Bio-Rad). Equal protein loading
was verified with Ponceau staining. Membranes were
blocked with 5% nonfat milk (Bio-Rad) or bovine
serum albumin (BSA; Santa Cruz Biotechnology,
Dallas, TX, USA) or fish skin gelatin (FSG; Sigma) in
Tris-buffered saline with 0.05% Tween 20 (TBS-T) for
2 h. Membranes were incubated with primary anti-
bodies in 5% nonfat milk or BSA in TBS-T against
late autophagy markers such as LC3 A/B, NBR1 and
SQSTM1/p62; early autophagy markers such as Class-
III PI3K, Beclin-1 and Rubicon; an autophago-
lysosomal marker RAB7; mTOR pathway markers
such as phospho-Akt [Thr308], phospho-Akt [Ser473],
Akt, phospho-mTOR [Ser2448], mTOR, phospho-
ribosomal S6 [Ser235/236], ribosomal S6 (Cell Signal-
ing Technology, Danvers, MA, USA), a modulator of
autophagy and mTOR pathway; pro- and anti-
apoptotic proteins such as BCL-2, BAX (Sigma)
caspase-3 (Novus Biologicals, Littleton, Colorado,
USA), necroptosis markers such as RIP1, RIP3 and
MLKL (Sigma); and GAPDH (Cell Signaling) or Actin
(Sigma) as loading controls. After three washes with
TBS-T, secondary antibody conjugated to horseradish
peroxidase was added for 1 h at room temperature
(in 5% nonfat milk in TBS-T; Cell Signaling). Signals
were detected with an enhanced chemiluminescence
kit (Bio-Rad) by Chemidoc XRS+ (Bio-Rad) and quan-
titated in Image Lab 4.1 software (Bio-Rad). Anti-
bodies bound to phospho-epitopes were removed with
Pierce Stripping Buffer (Thermo) before incubation
with antibodies detecting the total protein.
Statistical analysis
Values are expressed as mean ± standard error of mean
(SEM). Statistical analysis was performed between
groups by unpaired two-tailed t-test by using GraphPad
Prism 5 software. A p < 0.05 value was considered
significant.
Results
Elevated serum cholesterol level in hypercholesterolemic
rats
We examined body weight at the 12th week of the diet
and found no significant difference between groups
(NORM: 551.5 ± 13.0 g vs. CHOL: 529.4 ± 12.2 g; p <
0.05). Serum cholesterol, triglyceride and glucose param-
eters were measured in control and cholesterol-fed rats
to assess the state of lipid- and glucose homeostasis.
After the feeding period, serum cholesterol level was ele-
vated, although serum triglyceride and glucose levels
were unchanged in CHOL group as compared to the
NORM group, evidencing isolated hypercholesterolemia
in CHOL animals (Table 2). In addition, in a previous
study, CHOL animals displayed an altered lipoprotein
pattern after 12 weeks of feeding [34].
Hypercholesterolemia downregulates autophagy
In order to establish whether hypercholesterolemia
influences autophagy we measured cardiac expression
of autophagy markers by Western blot. Hearts of
cholesterol-fed animals exhibited a decrease in LC3-II,
Beclin-1, Rubicon, and RAB7 (Fig. 1b-e), consistent
with downregulation of autophagy initiation and
vesicle traffic despite upregulation of the Class-III
PI3K involved in autophagy initiation (Fig. 1f). No differ-
ence in the expression of markers of autophagic clearance
NBR1 and SQSTM1/p62 proteins was detected between
groups (Fig. 1g-h). These results suggest that both early
and late phases of autophagy were attenuated in the heart
of hypercholesterolemic rats.
Hypercholesterolemia activates mTOR in the heart
In order to investigate whether hypercholesterolemia af-
fects mTOR pathway we measured the phosphorylation
of mTOR and ribosomal S6 proteins. Our results
showed that there was no significant difference in the
expressions or phosphorylations of Akt and mTOR pro-
tein between groups; however, phosphorylation of ribo-
somal S6, a surrogate marker of mTOR complex
activity, was elevated in CHOL group (Fig. 2b-e). These
results indicate that mTOR activity was upregulated in
hypercholesterolemia.
Table 2 Plasma triglycerides, cholesterol, glucose levels in
NORM and CHOL groups
NORM CHOL
Glucose (mmol/L) 5.32 ± 0.14 5.23 ± 0.09
Cholesterol (mmol/L) 2.89 ± 0.22 4.09 ± 0.62*
Triglycerides (mmol/L) 2.17 ± 0.03 2.26 ± 0.05
Plasma cholesterol level was significantly elevated after 12 weeks of feeding in
CHOL animals. NORM (n = 9) vs. CHOL (n = 9), mean + SEM; *: p < 0.05)
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Apoptosis but not necroptosis is elevated in
hypercholesterolemia
We also investigated whether decreased autophagy in
hypercholesterolemia is associated with altered apoptotic
and necroptotic pathways. Expression of apoptotic
marker cleaved caspase-3 was significantly increased,
while BCL-2/BAX protein expression ratio was un-
changed (Fig. 3b-c). Furthermore, expression of RIP1,
RIP3 and MLKL proteins, major markers of necroptosis,
were unchanged (Fig. 3e-g). These results suggest that
hypercholesterolemia upregulates apoptosis but not
necroptosis in the heart.
Discussion
This is the first comprehensive analysis of cardiac au-
tophagy and programmed cell death pathways of apop-
tosis and necroptosis in hypercholesterolemic rats. Here
we have shown that hypercholesterolemia induces the
attenuation of cardiac autophagy in parallel with the ac-
tivation of mTOR pathway and an elevation of apoptosis.
Moreover, this is the first demonstration that isolated
hypercholesterolemia does not influence the expression
of major markers of cardiac necroptosis (for schematic
representation see Fig. 4).
In this study we showed first that isolated hypercholes-
terolemia downregulates cardiac autophagy and activates
mTOR pathway. Autophagy-related pathways were pre-
viously studied in various swine models of mixed hyper-
lipidemia, which presented somewhat divergent results.
Sellke et al. [14] studied swine models of mixed hyper-
lipidemia where they applied regional cardiac ischemia
and assessed autophagy in non-ischemic myocardium.
They demonstrated that cardiac mTOR activity was sig-
nificantly elevated while autophagy marker LC3-II was
diminished in hyperlipidemic Yucatan pigs. These find-
ings are in good alignment with our results shown here,
however, elsewhere hyperlipidemia decreased expression
of Beclin-1, but not of LC3-II in Yorkshire swine [36],
while in Ossabaw swine hyperlipidemia elevated cardiac
LC3-II and Beclin-1 proteins [37]. Similarly to these
findings, the status of cardiac autophagy in other meta-
bolic disorders was also found to be unclear. Recently
we showed that diet-induced obesity leads to decreased
induction of autophagy in response to fasting in mice
Fig. 1 Hypercholesterolemia downregulated cardiac autophagy. a Representative Western blots for autophagy-related proteins in the left ventricle
of NORM and CHOL rats. b-h Quantification of LC3-I/II, Beclin-1, Class III PI3K, NBR1, SQSTM1/p62, RAB7 and Rubicon protein expressions
as normalized to Actin. NORM (n = 4) vs. CHOL (n = 5); mean + SEM; *: p < 0.05)
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Fig. 2 Hypercholesterolemia activated mTOR pathway. a Representative Western blots for mTOR pathway-related proteins in the left ventricle
of NORM and CHOL rats. b-e Quantification of phospho-Akt [Ser473; Thr308], phospho-mTOR [Ser2448], and phospho-S6 [Ser235/236] protein
expressions as normalized to the corresponding total proteins. NORM (n = 4) vs. CHOL (n = 5); mean + SEM; *: p < 0.05)
Fig. 3 Hypercholesterolemia activated apoptosis, but had no effect on cardiac necroptosis. a Representative Western blots for apoptosis-related
protein expressions. b-c Quantification of cleaved caspase-3 expression normalized to Actin and ratio of BCL-2 to BAX. d Representative Western
blots for necroptosis-related proteins. e-g Quantification of RIP1, RIP3, MLKL and cleaved caspase-3 as normalized to Actin protein expression.
NORM (n = 5) vs. CHOL (n = 5); mean + SEM; *: p < 0.05)
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involving altered expression of numerous proteins re-
lated to metabolic pathways [15], which is in parallel to
our current findings. However, in Long-Evans rats fed
with high-fat diet we demonstrated only early signs of
decreased mitophagy, but no major changes in overall
cardiac autophagy or mTOR pathway [38]. In contrast,
elsewhere metabolic syndrome induced by high-fat feed-
ing increased cardiac LC3-II and SQSTM1/p62 in mice
[39]. Overall, these reports and our current study dem-
onstrate that complex metabolic disorders might modu-
late cardiac mTOR pathway and autophagy differentially
depending on the animal model applied, and they also
highlight that focused studies are necessary to decipher
the role of specific metabolic pathways on autophagy.
Our results also demonstrated that apoptosis was up-
regulated by isolated hypercholesterolemia in the rat
heart. We assessed an increased cleaved caspase-3 acti-
vation, however, the balance of pro- and anti-apoptotic
BCL-2 proteins was unaffected by isolated hypercholes-
terolemia. Similarly, Cheng et al. reported that 8 weeks
of cholesterol-enriched diet induced cardiac apoptosis in
hamsters, associated with increased expression of BID
and BAX [30]. These results correlate well with findings
of Zhu et al. who showed that 12 weeks of hypercholes-
terolemic diet elevated cardiac expression of BAX, de-
creased BCL-xL but did not affect caspase-3 in swine
[40]. Furthermore, Hsu et al. demonstrated that cardiac
cleaved PARP was increased in obese C57BL/6 mice on
a high fat diet [39]. On the contrary, Osipov et al.
showed that hyperlipidemia did not exacerbate cardiac
apoptosis after ischemia and reperfusion in a Yucatan
swine model based on the findings of decreased cleaved
PARP and no difference in activation of caspase-3 [29].
Hypercholesterolemia has also been shown to modulate
apoptosis in other tissue types. For example, Perales et
al. showed upregulated BAX expression in vascular
smooth muscle cells exposed to 25-hydroxycholesterol
[41]. Therefore, the majority of these results demon-
strates that there is a strong relationship between in-
creased cardiac apoptosis and hypercholesterolemia,
although different models of hypercholesterolemia dis-
play varying constellations of altered apoptotic markers.
Although several publications report elevated cardiac
apoptosis in hypercholesterolemia, data on cardiac
necroptosis is scarce. Indeed, this is the first study which
assessed the status of necroptosis in vivo in isolated hyper-
cholesterolemia. Here we demonstrate that the expression
of major markers of necroptosis are not modulated in the
heart of cholesterol-fed rats. However, in a similar model
of hypercholesterolemia, cardiac expression of RIP3
mRNA was increased [42], although no other measures of
necroptosis were assessed. Nevertheless, these findings
demonstrate that the effect of hypercholesterolemia on
cardiac necroptosis needs further investigation.
Limitations of this study are that the investigation was
performed only on male rats, therefore, we cannot ex-
clude the possibility that sex influences the effect of
hypercholesterolemia on cardiac death and survival
mechanisms. Furthermore, we did not follow food con-
sumption during the experiments. We did not investi-
gate either the presence of autophagosomes with
electron microscopy, or autophagic flux, or the phos-
phorylation of ribosomal S6 protein through the 90 kDa
ribosomal S6 kinase (RSK), which might contribute to
the phosphorylation of ribosomal S6 protein independ-
ently of the mTOR complex [43]. Another limitation is
that the effect of hypercholesterolemia on autophagy,
apoptosis, necroptosis and mTOR signaling pathways
was assessed only in the left ventricular myocardium.
Conclusions
In conclusion, this is the first comprehensive analysis of
autophagy and programmed cell death pathways in the
hearts of hypercholesterolemic rats, demonstrating that
autophagy is downregulated, while mTOR pathway and
apoptosis are upregulated. This imbalance between pro-
survival and death pathways might play a role in the
abolition of cardioprotection in hypercholesterolemia. In
addition, this is the first demonstration that expression
of major markers of cardiac necroptosis is not modu-
lated by isolated hypercholesterolemia.
Fig. 4 Schematic representation of the cardiac effect of
hypercholesterolemia on autophagy, apoptosis, necroptosis and
mTOR pathways
Giricz et al. Lipids in Health and Disease  (2017) 16:60 Page 6 of 8
Abbreviations
BAX: Apoptosis regulator BAX; BCA: Bicinchoninic acid; BCL-2: Apoptosis
regulator Bcl-2; BID: BH3-interacting domain death agonist protein;
BSA: Bovine serum albumin; CHOL: Hypercholesterolemic; Class-III
PI3K: Class-III phosphoinositide 3-kinase; FSG: Fish skin gelatin;
GAPDH: Glyceraldehyde 3-phosphate dehydrogenase; LC3: Microtubule-
associated protein light chain 3; MLKL: Mixed lineage kinase domain-like
protein; mTOR: Mammalian target of rapamycin; NBR1: Neighbor of
BRCA1 gene 1; NORM: Normocholesterolemic; PARP: Poly (ADP-ribose)
polymerase; PVDF: Polyvinylidene fluoride; RAB7: Ras-related protein
Rab-7a; RIP1: Receptor-interacting serine/threonine-protein kinase 1;
RIP3: Receptor-interacting serine/threonine-protein kinase 3;
RIPA: Radioimmunoprecipitation assay; RSK: 90 kDa ribosomal S6
kinase; Rubicon: Run domain Beclin-1-interacting and cysteine-rich
domain-containing protein; S6: Ribosomal S6 protein; SQSTM1/
p62: Sequestosome 1; TBS-T: Tris-buffered saline-Tween 20
Acknowledgements
We thank Melinda Károlyi-Szabó and Sebestyén Tuza for technical assistance.
Funding
The project is financed by Hungarian Scientific Research Fund (OTKA
K109737), Scientific Grant Agency of the Ministry of Education, Science,
Research and Sport of the Slovak Republic (VEGA 1/0638/12), Faculty
of Pharmacy, Comenius University in Bratislava, Slovak Republic (FaF
UK/19/2015). CC and ZG was supported by the János Bolyai Research
Scholarship of the Hungarian Academy of Sciences. ZVV was supported
by the National Program of Excellence (TÁMOP 4.2.4.A/1-11-1-2012-0001).
NHLBI P01 HL112730 to RAG.
Availability of data and materials
The dataset supporting the conclusions of this article are available upon
request to the corresponding author.
Authors’ contributions
ZG designed study, performed research, assisted with interpretation and
writing. GK performed experiments, assisted with analyses of results and
interpretation and writing. TR assisted with analyses of results and
interpretation and writing. AS, AA contributed to acquisition, analysis, and
interpretation of data. ZV, TB and CC performed experiments with animals.
PF and RAG designed the experiments, wrote and edited the manuscript.
All authors read and approved the final manuscript.
Competing interests
The authors have reported that they have no relationships relevant to the
contents of this paper to disclose.
Consent for publication
Not applicable.
Ethics approval and consent to participate
This investigation conforms to the Guide for the Care and Use of Laboratory
Animals published by the US National Institutes of Health (NIH publication
No. 85–23, revised 1996) and was approved by the animal ethics committee
of the University of Szeged, Szeged, Hungary.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Pharmacology and Pharmacotherapy, Faculty of Medicine,
Semmelweis University, Nagyvárad tér 4, H-1089 Budapest, Hungary.
2Department of Biochemistry, Faculty of Medicine, University of Szeged, Dóm
tér 9, H-6720 Szeged, Hungary. 3Department of Pharmacology and
Toxicology, Faculty of Pharmacy, Comenius University, Odbojárov 10, 83232
Bratislava, Slovakia. 4Heart Institute, Cedars-Sinai Medical Center, 127 S. San
Vicente Blvd., Los Angeles, CA 90048, USA. 5Pharmahungary Group, Szeged,
Hungary.
Received: 16 December 2016 Accepted: 14 March 2017
References
1. D’Annunzio V, Donato M, Buchholz B, Perez V, Miksztowicz V, Berg G, Gelpi
RJ. High cholesterol diet effects on ischemia-reperfusion injury of the heart.
Can J Physiol Pharmacol. 2012;90:1185–96.
2. Huang Y, Walker KE, Hanley F, Narula J, Houser SR, Tulenko TN. Cardiac
systolic and diastolic dysfunction after a cholesterol-rich diet. Circulation.
2004;109:97–102.
3. Onody A, Csonka C, Giricz Z, Ferdinandy P. Hyperlipidemia induced by a
cholesterol-rich diet leads to enhanced peroxynitrite formation in rat hearts.
Cardiovasc Res. 2003;58:663–70.
4. Sciarretta S, Zhai P, Volpe M, Sadoshima J. Pharmacological modulation of
autophagy during cardiac stress. J Cardiovasc Pharmacol. 2012;60:235–41.
210.1097/FJC.1090b1013e3182575f3182561.
5. Giricz Z, Mentzer Jr RM, Gottlieb RA. Autophagy, myocardial protection, and
the metabolic syndrome. J Cardiovasc Pharmacol. 2012;60:125–32.
6. Gustafsson ÅB, Gottlieb RA. Recycle or die: The role of autophagy in
cardioprotection. J Mol Cell Cardiol. 2008;44:654–61.
7. Yuan H, Perry CN, Huang C, Iwai-Kanai E, Carreira RS, Glembotski CC,
Gottlieb RA. LPS-induced autophagy is mediated by oxidative signaling in
cardiomyocytes and is associated with cytoprotection. Am J Physiol Heart
Circ Physiol. 2009;296:H470–479.
8. Hamacher-Brady A, Brady NR, Gottlieb RA. Enhancing macroautophagy
protects against ischemia/reperfusion injury in cardiac myocytes. J Biol
Chem. 2006;281:29776–87.
9. Gurusamy N, Lekli I, Mukherjee S, Ray D, Ahsan MK, Gherghiceanu M,
Popescu LM, Das DK. Cardioprotection by resveratrol: a novel mechanism
via autophagy involving the mTORC2 pathway. Cardiovasc Res. 2010;86:
103–12.
10. Hariharan N, Zhai P, Sadoshima J. Oxidative stress stimulates autophagic
flux during ischemia/reperfusion. Antioxid Redox Signal. 2011;14:2179–90.
11. Huang C, Yitzhaki S, Perry C, Liu W, Giricz Z, Mentzer Jr R, Gottlieb R.
Autophagy induced by ischemic preconditioning is essential for
cardioprotection. J Cardiovasc Transl Res. 2010;3:365–73.
12. Rohailla S, Clarizia N, Sourour M, Sourour W, Gelber N, Wei C, Li J, Redington
AN. Acute, delayed and chronic remote ischemic conditioning is associated
with downregulation of mTOR and enhanced autophagy signaling. PLoS
One. 2014;9:e111291.
13. Sengupta S, Peterson TR, Sabatini DM. Regulation of the mTOR complex 1
pathway by nutrients, growth factors, and stress. Mol Cell. 2010;40:310–22.
14. Glazer HP, Osipov RM, Clements RT, Sellke FW, Bianchi C.
Hypercholesterolemia is associated with hyperactive cardiac mTORC1 and
mTORC2 signaling. Cell Cycle. 2009;8:1738–46.
15. Andres AM, Kooren JA, Parker SJ, Tucker KC, Ravindran N, Ito BR, Huang
C, Venkatraman V, Van Eyk JE, Gottlieb RA, Mentzer Jr RM. Discordant
signaling and autophagy response to fasting in hearts of obese mice:
Implications for ischemia tolerance. Am J Physiol Heart Circ Physiol.
2016;311:H219–228.
16. Fenton RA, Dickson EW, Meyer TE, Dobson Jr JG. Aging reduces the
cardioprotective effect of ischemic preconditioning in the rat heart. J Mol
Cell Cardiol. 2000;32:1371–5.
17. Schulman D, Latchman DS, Yellon DM. Effect of aging on the ability of
preconditioning to protect rat hearts from ischemia-reperfusion injury. Am J
Physiol Heart Circ Physiol. 2001;281:H1630–1636.
18. Galagudza MM, Nekrasova MK, Syrenskii AV, Nifontov EM. Resistance
of the myocardium to ischemia and the efficacy of ischemic
preconditioning in experimental diabetes mellitus. Neurosci Behav
Physiol. 2007;37:489–93.
19. Kristiansen SB, Lofgren B, Stottrup NB, Khatir D, Nielsen-Kudsk JE, Nielsen TT,
Botker HE, Flyvbjerg A. Ischaemic preconditioning does not protect the
heart in obese and lean animal models of type 2 diabetes. Diabetologia.
2004;47:1716–21.
20. Yadav HN, Singh M, Sharma PL. Modulation of the cardioprotective effect
of ischemic preconditioning in hyperlipidaemic rat heart. Eur J Pharmacol.
2010;643:78–83.
21. Gupta V, Goyal R, Sharma PL. Preconditioning offers cardioprotection in
hyperlipidemic rat hearts: possible role of Dopamine (D2) signaling. BMC
Cardiovasc Disord. 2015;15:77.
Giricz et al. Lipids in Health and Disease  (2017) 16:60 Page 7 of 8
22. Giricz Z, Lalu MM, Csonka C, Bencsik P, Schulz R, Ferdinandy P.
Hyperlipidemia attenuates the infarct size-limiting effect of ischemic
preconditioning: role of matrix metalloproteinase-2 inhibition.
J Pharmacol Experimental Ther. 2006;316:154–61.
23. Gorbe A, Varga ZV, Kupai K, Bencsik P, Kocsis GF, Csont T, Boengler K,
Schulz R, Ferdinandy P. Cholesterol diet leads to attenuation of ischemic
preconditioning-induced cardiac protection: the role of connexin 43.
Am J Physiol Heart Circ Physiol. 2011;300:H1907–1913.
24. Ferdinandy P, Csonka C, Csont T, Szilvassy Z, Dux L. Rapid pacing-induced
preconditioning is recaptured by farnesol treatment in hearts of cholesterol-
fed rats: role of polyprenyl derivatives and nitric oxide. Mol Cell Biochem.
1998;186:27–34.
25. Kupai K, Csonka C, Fekete V, Odendaal L, van Rooyen J, Marais de W,
Csont T, Ferdinandy P. Cholesterol diet-induced hyperlipidemia impairs the
cardioprotective effect of postconditioning: role of peroxynitrite. Am J
Physiol Heart Circ Physiol. 2009;297:H1729–1735.
26. Nishida K, Yamaguchi O, Otsu K. Crosstalk between autophagy and
apoptosis in heart disease. Circ Res. 2008;103:343–51.
27. Gustafsson AB, Gottlieb RA. Bcl-2 family members and apoptosis, taken to
heart. Am J Physiol Cell Physiol. 2007;292:C45–51.
28. Jouan-Lanhouet S, Riquet F, Duprez L, Vanden Berghe T, Takahashi N,
Vandenabeele P. Necroptosis, in vivo detection in experimental disease
models. Semin Cell Dev Biol. 2014;35:2–13.
29. Osipov RM, Bianchi C, Feng J, Clements RT, Liu Y, Robich MP, Glazer HP,
Sodha NR, Sellke FW. Effect of hypercholesterolemia on myocardial necrosis
and apoptosis in the setting of ischemia-reperfusion. Circulation. 2009;120:
S22–30.
30. Cheng YC, Chang MH, Tsai CC, Chen TS, Fan CC, Lin CC, Lai CH, Tsai FJ,
Lin JA, Huang CY. Garlic oil attenuates the cardiac apoptosis in hamster-fed
with hypercholesterol diet. Food Chem. 2013;136:1296–302.
31. Zhang DW, Shao J, Lin J, Zhang N, Lu BJ, Lin SC, Dong MQ, Han J. RIP3, an
energy metabolism regulator that switches TNF-induced cell death from
apoptosis to necrosis. Science. 2009;325:332–6.
32. Vandenabeele P, Declercq W, Van Herreweghe F, Vanden Berghe T.
The role of the kinases RIP1 and RIP3 in TNF-induced necrosis.
Sci Signal. 2010;3:re4.
33. Ye YC, Wang HJ, Yu L, Tashiro S, Onodera S, Ikejima T. RIP1-mediated
mitochondrial dysfunction and ROS production contributed to tumor
necrosis factor alpha-induced L929 cell necroptosis and autophagy. Int
Immunopharmacol. 2012;14:674–82.
34. Varga ZV, Kupai K, Szucs G, Gaspar R, Paloczi J, Farago N, Zvara A, Puskas LG,
Razga Z, Tiszlavicz L, et al. MicroRNA-25-dependent up-regulation of NADPH
oxidase 4 (NOX4) mediates hypercholesterolemia-induced oxidative/
nitrative stress and subsequent dysfunction in the heart. J Mol Cell
Cardiol. 2013;62:111–21.
35. Csont T, Bereczki E, Bencsik P, Fodor G, Gorbe A, Zvara A, Csonka C,
Puskas LG, Santha M, Ferdinandy P. Hypercholesterolemia increases
myocardial oxidative and nitrosative stress thereby leading to cardiac
dysfunction in apoB-100 transgenic mice. Cardiovasc Res. 2007;76:
100–9.
36. Sabe AA, Elmadhun NY, Dalal RS, Robich MP, Sellke FW. Resveratrol
regulates autophagy signaling in chronically ischemic myocardium. J Thorac
Cardiovasc Surg. 2014;147:792–8. Discussion 798-799.
37. Sabe AA, Elmadhun NY, Sadek AA, Chu LM, Bianchi C, Sellke FW. Differential
effects of atorvastatin on autophagy in ischemic and nonischemic
myocardium in Ossabaw swine with metabolic syndrome. J Thorac
Cardiovasc Surg. 2014;148:3172–8.
38. Koncsos G, Varga ZV, Baranyai T, Boengler K, Rohrbach S, Li L, Schluter KD,
Schreckenberg R, Radovits T, Olah A, et al. Diastolic dysfunction in
prediabetic male rats: Role of mitochondrial oxidative stress. Am J Physiol
Heart Circ Physiol. 2016;311:H927–h943.
39. Hsu HC, Chen CY, Lee BC, Chen MF. High-fat diet induces cardiomyocyte
apoptosis via the inhibition of autophagy. Eur J Nutr. 2016;55:2245–54.
40. Zhu XY, Daghini E, Rodriguez-Porcel M, Chade AR, Napoli C, Lerman A,
Lerman LO. Redox-sensitive myocardial remodeling and dysfunction in
swine diet-induced experimental hypercholesterolemia. Atherosclerosis.
2007;193:62–9.
41. Perales S, Alejandre MJ, Palomino-Morales R, Torres C, Iglesias J, Linares A.
Effect of oxysterol-induced apoptosis of vascular smooth muscle cells on
experimental hypercholesterolemia. J Biomed Biotechnol. 2009;2009:456208.
42. Chtourou Y, Slima AB, Makni M, Gdoura R, Fetoui H. Naringenin protects
cardiac hypercholesterolemia-induced oxidative stress and subsequent
necroptosis in rats. Pharmacol Rep. 2015;67:1090–7.
43. Roux PP, Shahbazian D, Vu H, Holz MK, Cohen MS, Taunton J, Sonenberg N,
Blenis J. RAS/ERK signaling promotes site-specific ribosomal protein S6
phosphorylation via RSK and stimulates cap-dependent translation. J Biol
Chem. 2007;282:14056–64.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Giricz et al. Lipids in Health and Disease  (2017) 16:60 Page 8 of 8
